- NON-FINANCIAL REPORT
- JOIN US
- CONTACT US
-
NEURAXPHARM GROUP
See Neuraxpharm’s sites
Product | Indication | Dosage form | Strength |
---|---|---|---|
Dexketoprofen | Analgesic | Film-coated tablets | 12.5 and 25 mg |
Ketorolac | Analgesic | Film-coated tablets | 10 mg |
Paracetamol / Tramadol | Analgesic | Effervescent tablets | 325/37.5 mg |
Rizatriptan | Migraine | Orodispersable tablets | 5 and 10 mg |
Zolmitriptan | Migraine | Orodispersable tablets | 2.5 and 5 mg |
[*] Differentiated product
[**] Opioid
Listed products protected by valid patents are developed solely for purposes related to the development, preparation and submission of information to obtain a Marketing Authorisation. In particular these products are under development for uses related to the activities stated in Art. 10.6 of Directive 2001/83/EC amended by the Directive 2004/27/EC of the European Parliament and of the Council of 31 March 2004, i.e. activities carried out to obtain a Marketing Authorisation. None of the products are offered for sale or supplied to countries in which they could be in conflict with valid patents.
© Neuraxpharm / LESVI. All rights reserved.